Congenital

SCAI Sends Letter Supporting the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 (H.R.1691)

Read more about SCAI Sends Letter Supporting the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 (H.R.1691)

SCAI 2024 Fellows Courses

Read more about SCAI 2024 Fellows Courses

President’s Message—June 2024

Read more about President’s Message—June 2024

SCAI Comments on 2025 Medicare IPPS Proposed Rule

Read more about SCAI Comments on 2025 Medicare IPPS Proposed Rule

Share Your Examples of Onerous or Unusual Noncompete Agreements

Read more about Share Your Examples of Onerous or Unusual Noncompete Agreements

Rapid Takeaways From Late-Breaking Science at EuroPCR 2024

Read more about Rapid Takeaways From Late-Breaking Science at EuroPCR 2024

2024 Congenital Coding Update

Join our distinguished panelists to discuss updated CPT codes pertaining to pediatric CHD interventions.

Read more about 2024 Congenital Coding Update

First TAVI vs. SAVR Randomized Trial in Younger Low-Risk Patients With Severe Tricuspid or Bicuspid Aortic Valve Stenosis: Results From NOTION-2—Coverage of EuroPCR 2024

Read more about First TAVI vs. SAVR Randomized Trial in Younger Low-Risk Patients With Severe Tricuspid or Bicuspid Aortic Valve Stenosis: Results From NOTION-2—Coverage of EuroPCR 2024

SCAI Sends Letter Opposing Proposed Medical Imaging Licensure Legislation in Pennsylvania

Read more about SCAI Sends Letter Opposing Proposed Medical Imaging Licensure Legislation in Pennsylvania

SCAI Honors Members for Outstanding Service and Dedication

Read more about SCAI Honors Members for Outstanding Service and Dedication

Subscribe to Congenital

© Society for Cardiovascular Angiography & Interventions

SCAI^® is a registered trademark of the Society for Cardiovascular Angiography & Interventions.

All content found on the Society for Cardiovascular Angiography & Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.

Get in touch

1100 17th Street NW, Suite 400, Washington, DC 20036

202-741-9854 TEL

800-992-7224 TOLL-FREE

800-863-5202 FAX

[email protected]

Connect

Follow us on social media.